FDA Faces Cannabinoid-Lists Deadline Ahead of Hemp Clampdown
In about nine months, federal hemp laws are scheduled to significantly change in a way that industry stakeholders say would effectively upend the market by re-criminalizing most consumable cannabinoid products. But in the interim, the Food and Drug Administration (FDA) is facing a deadline to help inform future hemp policy.
Morris BeegleFebruary 6, 2026









